These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37158812)

  • 1. Positive effects of dietary supplementation with nutraceuticals on male subclinical hypogonadism: a pilot study.
    Iuliano S; Greco F; Seminara G; Zagari MC; Sgrò P; DI Gennaro G; Greco EA; Aversa A
    Minerva Endocrinol (Torino); 2023 Sep; 48(3):274-281. PubMed ID: 37158812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
    Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
    Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism.
    Naharci MI; Pinar M; Bolu E; Olgun A
    Endocr Pract; 2007 Oct; 13(6):629-35. PubMed ID: 17954419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can testosterone level be a good predictor of late-onset hypogonadism?
    Heidari R; Sajadi H; Pourmand A; Pourmand G
    Andrologia; 2015 May; 47(4):433-7. PubMed ID: 24773173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset hypogonadism: beyond testosterone.
    Foresta C; Calogero AE; Lombardo F; Lenzi A; Ferlin A
    Asian J Androl; 2015; 17(2):236-8. PubMed ID: 25248651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction.
    Corona G; Rastrelli G; Monami M; Melani C; Balzi D; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2011 Jul; 8(7):2098-105. PubMed ID: 21561538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transdermal testosterone or alpha-lipoic acid on erectile dysfunction and quality of life in patients with type 2 diabetes mellitus.
    Mitkov MD; Aleksandrova IY; Orbetzova MM
    Folia Med (Plovdiv); 2013; 55(1):55-63. PubMed ID: 23905488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data.
    Alwani M; Yassin A; Talib R; Al-Qudimat A; Aboumarzouk O; Al-Zoubi RM; Saad F; Haider KS; Al Ansari A
    Vasc Health Risk Manag; 2021; 17():497-508. PubMed ID: 34465997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy.
    Salman M; Yassin DJ; Shoukfeh H; Nettleship JE; Yassin A
    Aging Male; 2017 Mar; 20(1):45-48. PubMed ID: 28084147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.
    Kurobe M; Kawai K; Suetomi T; Iwamoto T; Waku N; Kawahara T; Kojima T; Joraku A; Miyazaki J; Nishiyama H
    Int J Urol; 2018 May; 25(5):457-462. PubMed ID: 29478250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction.
    Yassin AA; Nettleship JE; Salman M; Almehmadi Y
    Andrologia; 2017 May; 49(4):. PubMed ID: 27400881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular volume and clinical correlates of hypothalamic-pituitary-testicular function: A cross-sectional study in obese men.
    Tang Fui MN; Hoermann R; Wittert G; Grossmann M
    Asian J Androl; 2020; 22(4):354-359. PubMed ID: 31535628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of testosterone replacement therapy on insulin sensitivity and body composition in congenital hypogonadism: A prospective longitudinal follow-up study.
    Reddy KC; Yadav SB
    J Postgrad Med; 2021; 67(2):67-74. PubMed ID: 33942770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study.
    Francomano D; Bruzziches R; Barbaro G; Lenzi A; Aversa A
    J Endocrinol Invest; 2014 Apr; 37(4):401-11. PubMed ID: 24639122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study.
    Soares AH; Horie NC; Chiang LAP; Caramelli B; Matheus MG; Campos AH; Marti LC; Rocha FA; Mancini MC; Costa EMF; Cercato C
    Int J Obes (Lond); 2018 Jun; 42(5):953-963. PubMed ID: 29777228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men.
    Vermeulen A; Kaufman JM; Deslypere JP; Thomas G
    J Clin Endocrinol Metab; 1993 May; 76(5):1140-6. PubMed ID: 8496304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome.
    Filippi S; Vignozzi L; Morelli A; Chavalmane AK; Sarchielli E; Fibbi B; Saad F; Sandner P; Ruggiano P; Vannelli GB; Mannucci E; Maggi M
    J Sex Med; 2009 Dec; 6(12):3274-88. PubMed ID: 19732305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male subclinical hypogonadism and late-onset hypergonadotrophic hypogonadism: mechanisms, endothelial function, and interplay between reproductive hormones, undercarboxylated osteocalcin, and endothelial dysfunction.
    Matta RA; Farrage HM; Saedii AA; Abdelrahman MM
    Aging Male; 2022 Dec; 25(1):72-87. PubMed ID: 35291927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age.
    Hart RJ; Doherty DA; Mori TA; Adams LA; Huang RC; Minaee N; Handelsman DJ; McLachlan R; Norman RJ; Dickinson JE; Olynyk JK; Beilin LJ
    Hum Reprod; 2019 Mar; 34(3):389-402. PubMed ID: 30576537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.